Excessive adiposity (particularly visceral fat mass) increases the risks of developing metabolic syndrome. Women have lower deposit of visceral fat than men, and this pattern becomes diminished postmenopausally, but the underlying mechanism remains largely unknown. Here, we show that the gender difference in visceral fat distribution is controlled by an estradiol–autophagy axis. In C57BL/6J and wild-type control mice, a higher visceral fat mass was detected in the males than in the females, which was associated with lower expression of estrogen receptor α (ERα) and more active autophagy in males vs. females. However, deletion of ERα normalized autophagy activity and abolished the gender difference in visceral adiposity. In line with the adiposity-reducing effect of the ERα–autophagy axis, we found that downregulation of ERα and increased autophagy activity were required for adipogenesis, while induction of estradiol signaling dampened autophagy and drastically prevented adipogenesis. Mechanistically, the estradiol-ERα signaling activated mTOR, which phosphorylated and inhibited ULK1, thereby suppressing autophagy and adipogenesis. Together, our study suggests that the lower visceral adiposity in the females (vs. the males) arises from a more active estradiol-ERα signaling, which tunes down autophagy and adipogenesis.
Mitochondrial uncoupling proteins (UCPs) are inducible and play an important role in
metabolic and redox homeostasis. Recent studies have suggested that FoxO1 controls
mitochondrial biogenesis and morphology, but it remains largely unknown how FoxO1 may
regulate mitochondrial UCPs. Here we show that FoxO1 interacted with transcription factor
EB (Tfeb), a key regulator of autophagosome and lysosome, and mediated the expression of
UCP1, UCP2 and UCP3 differentially via autophagy in adipocytes. UCP1 was down-regulated
but UCP2 and UCP3 were upregulated during adipocyte differentiation, which was associated
with increased Tfeb and autophagy activity. However, inhibition of FoxO1 suppressed Tfeb
and autophagy, attenuating UCP2 and UCP3 but increasing UCP1 expression. Pharmacological
blockade of autophagy recapitulated the effects of FoxO1 inhibition on UCPs. Chromatin
immunoprecipitation assay demonstrated that FoxO1 interacted with Tfeb by directly binding
to its promoter, and silencing FoxO1 led to drastic decrease in Tfeb transcript and
protein levels. These data provide the first line of evidence that FoxO1 interacts with
Tfeb to regulate autophagy and UCP expression in adipocytes. Dysregulation of
FoxO1→autophagy→UCP pathway may account for metabolic changes in obesity.
Targeting TEAD autopalmitoylation has been proposed as a therapeutic approach for YAP-dependent cancers. Here we show that TEAD palmitoylation inhibitor MGH-CP1 and analogues block cancer cell “stemness”, organ overgrowth and tumor initiation in vitro and in vivo. MGH-CP1 sensitivity correlates significantly with YAP-dependency in a large panel of cancer cell lines. However, TEAD inhibition or YAP/TAZ knockdown leads to transient inhibition of cell cycle progression without inducing cell death, undermining their potential therapeutic utilities. We further reveal that TEAD inhibition or YAP/TAZ silencing leads to VGLL3-mediated transcriptional activation of SOX4/PI3K/AKT signaling axis, which contributes to cancer cell survival and confers therapeutic resistance to TEAD inhibitors. Consistently, combination of TEAD and AKT inhibitors exhibits strong synergy in inducing cancer cell death. Our work characterizes the therapeutic opportunities and limitations of TEAD palmitoylation inhibitors in cancers, and uncovers an intrinsic molecular mechanism, which confers potential therapeutic resistance.
Sex difference in adiposity has long been recognized but the mechanism remains incompletely understood. Previous studies suggested that adiposity was regulated by autophagy in response to energy status change. Here, we show that the energy sensor Sirt1 mediates sex difference in adiposity by regulating autophagy and adipogenesis in partnership with estrogen receptor α (ERα). Autophagy and adipogenesis were suppressed by Sirt1 activation or overexpression, which was associated with reduced sex difference in adiposity. Mechanistically, Sirt1 deacetylated and activated AKT and STAT3, resulting in suppression of autophagy and adipogenesis via mTOR-ULK1 and p55 cascades. ERα induced Sirt1 expression and inhibited autophagy in adipocytes, while silencing Sirt1 reversed the effects of ERα on autophagy and promoted adipogenesis. Moreover, Sirt1 deacetylated ERα, which constituted a positive feedback loop in the regulation of autophagy and adiposity. Our results revealed a new mechanism of Sirt1 regulating autophagy in adipocytes and shed light on sex difference in adiposity.
In recent years, massive hydrophobic/superhydrophobic metal-organic frameworks (MOFs) have been developed. These hydrophobic MOFs not only retain rich structural variety, highly crystalline frameworks, and uniform micropores, but also lower affinity...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.